- Home
- AXSM vs UMBF Comparison
AXSM vs UMBF Comparison
Compare AXSM & UMBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- UMBF
- Stock Information
- Founded
- AXSM 2012
- UMBF 1913
- Country
- AXSM United States
- UMBF United States
- Employees
- AXSM N/A
- UMBF N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- UMBF Major Banks
- Sector
- AXSM Health Care
- UMBF Finance
- Exchange
- AXSM Nasdaq
- UMBF Nasdaq
- Market Cap
- AXSM 4.7B
- UMBF 5.2B
- IPO Year
- AXSM 2015
- UMBF N/A
- Fundamental
- Price
- AXSM $90.73
- UMBF $114.61
- Analyst Decision
- AXSM Strong Buy
- UMBF Buy
- Analyst Count
- AXSM 14
- UMBF 7
- Target Price
- AXSM $125.93
- UMBF $123.14
- AVG Volume (30 Days)
- AXSM 499.7K
- UMBF 404.6K
- Earning Date
- AXSM 02-18-2025
- UMBF 01-28-2025
- Dividend Yield
- AXSM N/A
- UMBF 1.40%
- EPS Growth
- AXSM N/A
- UMBF 2.85
- EPS
- AXSM N/A
- UMBF 8.01
- Revenue
- AXSM $338,457,000.00
- UMBF $1,523,550,000.00
- Revenue This Year
- AXSM $44.89
- UMBF N/A
- Revenue Next Year
- AXSM $68.41
- UMBF $46.14
- P/E Ratio
- AXSM N/A
- UMBF $14.30
- Revenue Growth
- AXSM 51.47
- UMBF 7.93
- 52 Week Low
- AXSM $64.11
- UMBF $76.00
- 52 Week High
- AXSM $105.00
- UMBF $129.94
- Technical
- Relative Strength Index (RSI)
- AXSM 42.16
- UMBF 37.92
- Support Level
- AXSM $89.09
- UMBF $120.42
- Resistance Level
- AXSM $94.64
- UMBF $123.55
- Average True Range (ATR)
- AXSM 3.64
- UMBF 3.65
- MACD
- AXSM -1.14
- UMBF -1.77
- Stochastic Oscillator
- AXSM 20.64
- UMBF 15.64
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About UMBF UMB Financial Corporation
UMB Financial Corp, or UMBF, is a financial services holding company offering a suite of banking, asset management, and health spending solutions. Its customer base includes commercial, institutional, and personal customers across the United States. The company's banking subsidiaries own and operate banking and wealth-management centers mostly throughout the Midwest and Southwest regions of the U.S. Subsidiaries of the holding company and its lead bank, UMB Bank, include mutual fund and alternative investment services groups, single-purpose companies that deal with brokerage services and insurance, and a registered investment advisory. The bank's revenue is split nearly evenly between interest income and noninterest income.